Study on improving national essential drug policy

Chinese Pharmaceutical Journal

Volumn 44, Issue 2, 2009, Pages 158-160

  Guan, Xiao Dong ^a   Shi, Lu Wen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL STUDY; DRUG CONTROL; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG MONITORING; GOVERNMENT; HEALTH CARE POLICY; PRESCRIPTION; QUALITY CONTROL;

EID: 63849320983     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. WHO.How to Develop and Implement a National Drug Policy [M]. Second Edition. Geneva, 2001: 7.
2. MENG R, TANG D L, CHEN F L. Discussion of the relation between drugs access and rational use and National Essential Drug Policy [J]. China Pharm, 2005, 8(8): 604-606.
3. WHO. How to Develop and implement a National Drug Policy [M]. Second Edition. Geneva, 2001: 14-15.
4. TAND J B. The new connotation of rational drug use in the new century [J]. China Pharm, 2004, 7(1): 1.
5. LI Q, ZENG F D. Establishment and implementation of national drug policy [J]. Chin J Pharmacoepiolemiol, 2002, 11 (6): 281-283.
6. JIANG B, SHI L W. The analysis of China's drug policy in recent years[J]. Chin Pharm Aff, 2005, 19(3): 148-151.
7. WANG B G,ZHANG Z W. The core policy of promoting rational drug use [J]. Foreign Med Sci Series Hasp Manage, 6: 37-40.
8. MENG R. analysis on aftereffects of weak implementation of national essential drug policy and measures for strengthened implementation [J]. J China Pharm, 2006, 17 (8): 564-567.
9. DONG C H, LI D K, WU J, et al. Essential medicine system- Theories and experiences [J]. Chin Pharm J, 2009, 44(1): 2.
10. LI S L, CAO L Y, LAN F. Essential drugs in the adjustment of evidence-based evaluation [J]. Chin Pharm Aff, 2003, 17 (6): 337-339.
11. LIU J, QIAN L P, ZHANG X P. Delhi model of the promotion of essential drugs [J]. Foreign Med Sci (SocMed), 2003, 6 (20): 76-80.